Us europe rotavirus testing market

us europe rotavirus testing market The study analyzes the enteric disease testing market for 12 major types that includes campylobacteriosis, salmonellosis, giardiasis, cryptosporidiosis, amebiasis, norovirus infection and clostridium difficile mediated infection.

Us europe rotavirus testing market description

The factors influencing the growth of enteric disease testing and therapeutic market are higher incidence of infectious diseases, overcrowded human population, poverty and lack of education about health and safety standards, unavailability of safe drinking water in many parts of the world and increasing microbial resistance to antibiotics. Download presentation factors influencing for the development world rotavirus diagnostic testing market - powerpoint ppt presentation. Based on geography, global gastrointestinal infection testing market is segmented into five key regions viz north america, latin america, europe, asia pacific, and middle east & africa. Rotavirus infections are highly seasonal in the united states and europe but occur year round in india eighty percent of children in india were infected in the first year of life, and severe infections were fatal for about one in 200 children.

The research report titled “united states pediatric vaccine market 2017 – demand, insights, analysis, opportunities segmentation and forecast to 2024” examines the market dynamics, competitive landscape and discusses major trends. Global enteric disease testing and therapeutic market report offers insights on drivers & opportunities and key segments to help in gaining information about past progress, current dynamics, and scenario for the forecast period. Immunocard stat ® rotavirus provides accurate results for a differential diagnosis in just minutes in fact, more laboratories trust meridian for rapid detection of rotavirus than any other diagnostics manufacturer – over 60% of labs performing rotavirus testing are using a meridian product.

This report presents test volumes, sale forecasts and supplier shares for the us, europe (france, germany, italy, spain, uk) and japan the report provides volume and sales forecasts for rotavirus tests performed in the following market segments. Complete report $35,500datapack (test volumes, sales forecasts, supplier shares) $22,400 vpgmarketresearchcom's new report is a seven-country strategic analysis of the major business opportunities emerging in the automated microbiology market during the next five years. The report presents a detailed analysis of the cryptosporidium diagnostics market in the us, europe, (france, germany, italy, spain, uk) and japan current scientific views on the cryptosporidium definition, epidemiology and etiology are reviewed.

1 introduction rotavirus is the leading cause of severe gastroenteritis in children under five years of age prior to the introduction of rotavirus vaccines in europe in 2006, it was estimated that 36 million episodes of rotavirus disease occurred annually among the 236 million children younger than 5 years of age every year, rotavirus accounted for 231 deaths, over 87,000. Global enteric disease testing therapeutics market is segmented into campylobacter, cryptosporidium, e-coli, enteroviruses, rhinoviruses, rotavirus (reovirus), salmonellosis and shigellosis e-coli is the leading bacteria that cause the enteric disorders among children. Introduction rotavirus is a leading cause of severe, acute gastroenteritis among infanrs and young children throughout the world, and is responsible for an estimated 527,000 deaths among children under age 5 years each yearl. This report presents detailed analysis of the enteric disease market in the us, europe (france, germany, italy, spain, uk) and japan current scientific views on epidemiology and etiology are presented for campylobacter , cryptosporidium , e coli, enterovirus , rhinovirus , rotavirus , salmonella , shigella , vibrio and yersinia. Geographically, the global food pathogen testing market is divided among north america, europe, asia-pacific, and rest of the world north america is said to be at the top in the global food pathogen testing market due to the increased use of advanced technologies.

The immunization rate for children is at an all-time high of 80%, according to the centers for disease control and prevention (cdc) but in light of the recent withdrawal from the market of a. The report presents a detailed analysis of the rotavirus diagnostics market in the us, europe (france, germany, italy, spain, uk) and japan current scientific views on the rotavirus definition. The global enteric disease testing market is estimated to reach us$ 49 billion by 2023, growing at a cagr of 54% over the forecast period, due to higher demand for molecular diagnostics based methods of early detection and prognosis.

  • Issuu is a digital publishing platform that makes it simple to publish magazines, catalogs, newspapers, books, and more online easily share your publications and get them in front of issuu’s.
  • The report presents a detailed analysis of the rotavirus diagnostics market in the us, europe (france, germany, italy, spain, uk) and japan current scientific.

[211 pages report] check for discount on 2018 global molecular diagnostics market: us, europe, japan--sales and market shares by product and country report by venture planning group france aids testing market estimated sales by major supplier germany rotavirus testing market estimated sales by major supplier. Rotavirus infections drug market report is an intelligence research on present competitive situation of rotavirus infections drug industry focusing on business strategies of the key players, compound annual growth rate, drivers and trends of rotavirus infections drug market fundamental dynamics during the forecast period (2018-2025. Based on geography, the global enteric disease testing market is divided into north america, europe, asia pacific, latin america, and the middle east and africa in 2012, in terms of growth and potential, asia pacific accounted for more than 50% of the global enteric disease testing market. This vaccine was withdrawn from the us market in 1999, the usa, and europe demonstrated 85–98% vaccine efficacy against severe rotavirus gastroenteritis intussusception among recipients of rotavirus vaccine—united states, 1998-1999 mmwr morb mortal wkly rep 199948(27):577–81.

2018.